Medicine & Life Sciences
Leishmaniasis Vaccines
100%
Cutaneous Leishmaniasis
74%
Mucocutaneous Leishmaniasis
49%
Economics
45%
Vaccines
44%
Costs and Cost Analysis
36%
Colombia
34%
Latin America
34%
Diffuse Cutaneous Leishmaniasis
26%
Human Migration
23%
Bolivia
21%
Ecuador
20%
Conservation of Natural Resources
20%
Venezuela
19%
Neglected Diseases
19%
Peru
18%
Cost Savings
16%
Mexico
15%
Computer Simulation
13%
Brazil
13%
Epidemics
12%
Drug Therapy
8%
Population
5%
Therapeutics
2%
Agriculture & Biology
cutaneous leishmaniasis
77%
economic valuation
61%
vaccines
50%
leishmaniasis
29%
Latin America
27%
Colombia
23%
chaparral
17%
tropical diseases
16%
duration
14%
deforestation
14%
product development
13%
Bolivia
13%
computer simulation
12%
Ecuador
12%
cost effectiveness
12%
Venezuela
12%
Peru
12%
drug therapy
11%
Mexico
9%
economics
7%
Brazil
7%
Social Sciences
economic value
68%
costs
33%
Colombia
22%
Latin America
19%
Bolivia
13%
Ecuador
12%
Venezuela
12%
Peru
12%
savings
11%
Mexico
9%
Brazil
8%
scenario
8%
migration
8%
economics
4%